STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
58
13F, latest reported quarter
Conversions, 180 days
13
Codes C/M, not in net · $2.3M priced
What the filings say about USCB
Insiders, 180 days
-$4.5M net sold
4 sellers · 0% of sales under a 10b5-1 plan
Uscb Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, USCB FINANCIAL HOLDINGS, INC. insiders sold a net $4.5M of stock across 63 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Mar 7, 2026.
The trade is 3.2% of the 31,521 shares held after it.
2 other insiders sold within 30 days.
58 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Operations & IT COLLAZO ANDRES sold about $19.0K of USCB on Jun 8, 2026; 2 other insiders sold within 30 days and 58 funds added in the latest 13F quarter.
15 earlier Form 4 trades (code P or S) here by this insider (2 buys, 13 sales), the last on May 20, 2026.
The trade is 20.3% of the 242,945 shares held after it.
3 other insiders sold within 30 days.
58 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO DE LA AGUILERA LUIS sold about $904.3K of USCB on May 21, 2026; 3 other insiders sold within 30 days and 58 funds added in the latest 13F quarter.
14 earlier Form 4 trades (code P or S) here by this insider (2 buys, 12 sales), the last on May 19, 2026.
The trade is 15.2% of the 242,945 shares held after it.
3 other insiders sold within 30 days.
58 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO DE LA AGUILERA LUIS sold about $668.4K of USCB on May 20, 2026; 3 other insiders sold within 30 days and 58 funds added in the latest 13F quarter.
13 earlier Form 4 trades (code P or S) here by this insider (2 buys, 11 sales), the last on May 18, 2026.
The trade is 2.0% of the 242,945 shares held after it.
3 other insiders sold within 30 days.
58 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO DE LA AGUILERA LUIS sold about $88.8K of USCB on May 19, 2026; 3 other insiders sold within 30 days and 58 funds added in the latest 13F quarter.
12 earlier Form 4 trades (code P or S) here by this insider (2 buys, 10 sales), the last on May 15, 2026.
The trade is 1.0% of the 242,945 shares held after it.
3 other insiders sold within 30 days.
58 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President and CEO DE LA AGUILERA LUIS sold about $44.9K of USCB on May 18, 2026; 3 other insiders sold within 30 days and 58 funds added in the latest 13F quarter.
63 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
USCB planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
USCB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
RMB Mendon Financial Services Fund
$11.3M position · as of 2026-06-30
4.4%
Keeley Small Cap Fund
$695.6K position · as of 2026-06-30
0.5%
Adara Smaller Companies Fund
$2.5M position · as of 2026-05-31
0.3%
Ultra-Small Company Market Fund
$306.9K position · as of 2026-06-30
0.2%
T. Rowe Price Small-Cap Stock Fund, Inc.
$14.5M position · as of 2026-06-30
0.2%
T. Rowe Price Institutional Small-Cap Stock Fund
$7.6M position · as of 2026-06-30
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $4.5M sold by insiders over 180 days, 58 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$49.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM USCB
FY Dec 2025
$42.5M
FY Dec 2024
$34.5M
FY Dec 2023
$22.4M
FY Dec 2022
$28.9M
FY Dec 2021
$21.4M
Jun 2026
$24.2M
Mar 2026
$15.0M
Dec 2025
-$10.1M
Sep 2025
$20.0M
Jun 2025
$18.0M
Mar 2025
$14.6M
Dec 2024
-$3.0M
Sep 2024
$11.2M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity USCB
FY Dec 2025
+12.1%
FY Dec 2024
+12.1%
FY Dec 2023
+8.8%
FY Dec 2022
+10.4%
FY Dec 2021
+11.2%
Jun 2026
+12.4%
Mar 2026
+12.4%
Dec 2025
+12.1%
Sep 2025
+15.0%
Jun 2025
+13.7%
Mar 2025
+13.2%
Dec 2024
+12.1%
Sep 2024
+10.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets USCB
FY Dec 2025
+1.0%
FY Dec 2024
+1.0%
FY Dec 2023
+0.7%
FY Dec 2022
+1.0%
FY Dec 2021
+1.3%
Jun 2026
+1.0%
Mar 2026
+1.0%
Dec 2025
+1.0%
Sep 2025
+1.2%
Jun 2025
+1.1%
Mar 2025
+1.1%
Dec 2024
+1.0%
Sep 2024
+0.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.93x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing USCB
FY Dec 2025
13.85x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
13.20x
Mar 2026
12.70x
Dec 2025
13.85x
Sep 2025
11.11x
Jun 2025
11.25x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+13.3%
TTM free cash flow over market value at close 2026-10-27
FCF yield USCB
FY Dec 2025
+12.7%
FY Dec 2024
+9.8%
FY Dec 2023
+9.3%
FY Dec 2022
+11.8%
FY Dec 2021
n/a
Jun 2026
+13.1%
Mar 2026
+12.7%
Dec 2025
+12.7%
Sep 2025
+14.2%
Jun 2025
+12.3%
Mar 2025
+11.0%
Dec 2024
+9.8%
Sep 2024
+10.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
2.38x
P/E over trailing EPS growth of 5%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing USCB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
2.43x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
USCB ranks highest on risk and compliance (64th percentile) and profitability (55th), and lowest on insider conviction (6th), among Banks peers.
Profitability
55
Inputs
Return on equity+12.4% · 70 pct, sector of 327
Return on assets+1.0% · 40 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Insider conviction
6
Inputs
Net Form 4 buying (codes P and S), 180d-$4.5M · 12 pct, sector of 274
Insider buyers, 180d0 · 0 pct, sector of 274
Institutional and government
25
Inputs
Funds adding, latest quarter58 · 25 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
64
Inputs
Short interest, % of float+1.8% · 64 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Growth, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
USCB filings, in plain words
Are Uscb Financial insiders buying or selling USCB?
In the 180 days to 2026-10-28, Uscb Financial insiders were net sellers, a net $4.5M across purchases and sales reported on Form 4, by 4 sellers.
Read the full summary
In the 180 days to 2026-10-28, Uscb Financial insiders were net sellers of USCB, a net $4.5M across purchases and sales reported on Form 4 by 4 sellers. None of the 15 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.